Bengaluru, India

Ravi Kotrabasaiah Ujjinamatada

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Karnataka, IN (2016 - 2019)
  • Anekal Taluk Bangalore, IN (2019)
  • Bengaluru, IN (2022)

Company Filing History:


Years Active: 2016-2022

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Innovations and Contributions of Ravi Kotrabasaiah Ujjinamatada

Introduction

Ravi Kotrabasaiah Ujjinamatada is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors and kinases. With a total of four patents to his name, Ujjinamatada's work is recognized for its potential therapeutic applications.

Latest Patents

One of his latest patents involves substituted tetrahydroquinolinone compounds as ROR gamma modulators. This invention provides compounds that are therapeutically useful as modulators of Retinoic acid receptor-related orphan receptors (RORs), specifically as RORγ modulators. These compounds are aimed at treating and preventing diseases mediated by the RORγ receptor. Another significant patent focuses on protein kinase inhibitors, where a compound of a specific formula is disclosed. These compounds possess utility as FGFR inhibitors and are useful in treating conditions where FGFR kinase inhibition is desired, such as cancer.

Career Highlights

Throughout his career, Ujjinamatada has worked with prominent companies in the pharmaceutical industry, including Orion Corporation and Aurigene Discovery Technologies Limited. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Ujjinamatada has collaborated with various professionals in his field, including Subhendu Mukherjee and Tero Linnanen. These collaborations have likely enhanced his research and development efforts, leading to impactful inventions.

Conclusion

Ravi Kotrabasaiah Ujjinamatada's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to advancing medical science. His work continues to hold promise for the treatment of various diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…